US Map / Nevada
State NV

Clinical Trials in Nevada

Nevada is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Nevada and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 85 actively recruiting studies with Nevada sites out of 85 registered in total. The busiest research areas in Nevada are Obesity, Breast Cancer, Acute Myeloid Leukemia. Leading sponsors running trials in the state include AstraZeneca, Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network. By stage, Nevada trials break down as Phase 1 (7), Phase 2 (22), Phase 3 (40), Phase 4 (6).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
85
Recruiting Now
85
← Back to US Map
Top Conditions in Nevada
Obesity (3)Breast Cancer (3)Acute Myeloid Leukemia (3)Endometrial Cancer (3)Systemic Lupus Erythematosus (2)ADHD (2)Overweight (2)Crohn's Disease (2)Atherosclerotic Cardiovascular Disease (1)Major Depressive Disorder (MDD) (1)Diabetic Retinopathy (1)Anatomic Stage IV Breast Cancer AJCC v8 (1)

Frequently Asked Questions — Clinical Trials in Nevada

How many clinical trials are currently recruiting in Nevada?
ClinicalMetric currently tracks 85 actively recruiting clinical trials with at least one location in Nevada. The total number of registered studies—including active but not currently enrolling trials—is 85. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Nevada?
Nevada hosts clinical trials across a broad range of medical conditions, including Obesity, Breast Cancer, Acute Myeloid Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Nevada serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Nevada?
To join a clinical trial in Nevada, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Nevada maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Nevada

NCT07222800 Phase 3
Recruiting
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in...
Condition
Intestinal Neoplasms
Enrollment
800 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
View Trial →
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
View Trial →
NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endo...
Condition
Endometrial Cancer
Enrollment
268 pts
Location
United States, Austria, Canada
Sponsor
Kartos Therapeutics, Inc.
View Trial →
NCT05894239 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Ph...
Condition
Metastatic Breast Cancer
Enrollment
230 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
View Trial →
NCT07481630 Phase 3
Recruiting
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People W...
Condition
Obesity
Enrollment
400 pts
Location
United States, Australia, Bulgaria
Sponsor
Novo Nordisk A/S
View Trial →
NCT06226883 Phase 2
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Activ...
Condition
Inflammatory Bowel Diseases
Enrollment
385 pts
Location
United States, Australia, Austria
Sponsor
Morphic Therapeutic, Inc. (A W
View Trial →
NCT07298395 Phase 2
Recruiting
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Condition
Atopic Dermatitis (AD)
Enrollment
60 pts
Location
United States
Sponsor
Enveda Therapeutics
View Trial →
NCT06749457 Phase 1, Phase 2
Recruiting
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase...
Condition
Staphylococcus Aureus
Enrollment
231 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT04853251 Phase 4
Recruiting
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
188 pts
Location
United States
Sponsor
Genentech, Inc.
View Trial →
NCT07209111 Phase 2
Recruiting
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (M...
Condition
Neoplasm Malignant
Enrollment
150 pts
Location
United States, Australia, Canada
Sponsor
Merck Sharp & Dohme LLC
View Trial →
Page 4 of 4 — 85 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology